Tuesday, November 11, 2014 9:03:52 AM
Implant Sciences signs TSA IDIQ Contract for up to $162 million dollars for explosive trace detection systems
Indefinite Delivery / Indefinite Quantity Contract for QS-B220s
http://tinyurl.com/mhfulf2
WILMINGTON, Mass., Nov. 11, 2014 /PRNewswire/ -- Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has entered into an Indefinite Delivery / Indefinite Quantity (IDIQ) contract with the United States Transportation Security Administration (TSA) for its QS-B220 desktop explosives trace detectors, which recently received TSA qualification for airport checkpoint passenger and baggage screening. The IDIQ, a necessary prerequisite for competing for TSA's annual trace detection procurements, establishes contract terms under which the TSA could purchase up to $162 million of equipment and services.
"We are very pleased to receive an IDIQ of this magnitude from the TSA, just weeks after receiving approval for baggage and passenger screening. With this agreement, Implant Sciences becomes the first non-radioactive ETD manufacturer for passenger and baggage screening in airports. This is a testament to the performance and value delivered by our next-generation explosives trace detectors," stated Implant Sciences' CEO, Glenn D. Bolduc.
Indefinite Delivery / Indefinite Quantity Contract for QS-B220s
http://tinyurl.com/mhfulf2
WILMINGTON, Mass., Nov. 11, 2014 /PRNewswire/ -- Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has entered into an Indefinite Delivery / Indefinite Quantity (IDIQ) contract with the United States Transportation Security Administration (TSA) for its QS-B220 desktop explosives trace detectors, which recently received TSA qualification for airport checkpoint passenger and baggage screening. The IDIQ, a necessary prerequisite for competing for TSA's annual trace detection procurements, establishes contract terms under which the TSA could purchase up to $162 million of equipment and services.
"We are very pleased to receive an IDIQ of this magnitude from the TSA, just weeks after receiving approval for baggage and passenger screening. With this agreement, Implant Sciences becomes the first non-radioactive ETD manufacturer for passenger and baggage screening in airports. This is a testament to the performance and value delivered by our next-generation explosives trace detectors," stated Implant Sciences' CEO, Glenn D. Bolduc.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
